» Articles » PMID: 33406768

Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Trophoblast Functions

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Jan 7
PMID 33406768
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Peroxisome proliferator-activated receptors (PPARα, PPAR, and PPAR) belong to the transcription factor family, and they are highly expressed in all types of trophoblast during pregnancy. The present review discusses currently published papers that are related to the regulation of PPARs via lipid metabolism, glucose metabolism, and amino acid metabolism to affect trophoblast physiological conditions, including differentiation, maturation, secretion, fusion, proliferation, migration, and invasion. Recent pieces of evidence have proven that the dysfunctions of PPARs in trophoblast lead to several related pregnancy diseases such as recurrent miscarriage, preeclampsia, intrauterine growth restriction, and gestational diabetes mellitus. Moreover, the underlying mechanisms of PPARs in the control of these processes have been discussed as well. Finally, this review's purposes are to provide more knowledge about the role of PPARs in normal and disturbed pregnancy with trophoblast, so as to find PPAR ligands as a potential therapeutic target in the treatment and prevention of adverse pregnancy outcomes.

Citing Articles

Alpha-lipoic acid upregulates the PPARγ/NRF2/GPX4 signal pathway to inhibit ferroptosis in the pathogenesis of unexplained recurrent pregnancy loss.

Zhao Y, Zhao X, Feng X Open Med (Wars). 2024; 19(1):20240963.

PMID: 38859880 PMC: 11163161. DOI: 10.1515/med-2024-0963.


GG powder supplementation alleviates intestinal injury in piglets challenged by porcine epidemic diarrhea virus.

Xu Z, Zhang Q, Wu M, Zhang Y, Li Z, Li H Front Cell Infect Microbiol. 2024; 14:1371916.

PMID: 38716199 PMC: 11075637. DOI: 10.3389/fcimb.2024.1371916.


Aberrant trophoblastic differentiation in human cancer: An emerging novel therapeutic target (Review).

Chang C, Chen Y, Wang Y, Chen H, Hsu C, Lin K Oncol Rep. 2024; 51(3).

PMID: 38240107 PMC: 10823338. DOI: 10.3892/or.2024.8701.


An Overview of the Role of Peroxisome Proliferator-activated Receptors in Liver Diseases.

Changizi Z, Kajbaf F, Moslehi A J Clin Transl Hepatol. 2024; 11(7):1542-1552.

PMID: 38161499 PMC: 10752810. DOI: 10.14218/JCTH.2023.00334.


Beyond energy and growth: the role of metabolism in developmental signaling, cell behavior and diapause.

Tippetts T, Sieber M, Solmonson A Development. 2023; 150(20).

PMID: 37883062 PMC: 10652041. DOI: 10.1242/dev.201610.


References
1.
Tarrade A, Schoonjans K, Guibourdenche J, Bidart J, Vidaud M, Auwerx J . PPAR gamma/RXR alpha heterodimers are involved in human CG beta synthesis and human trophoblast differentiation. Endocrinology. 2001; 142(10):4504-14. DOI: 10.1210/endo.142.10.8448. View

2.
Escher P, Wahli W . Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutat Res. 2000; 448(2):121-38. DOI: 10.1016/s0027-5107(99)00231-6. View

3.
Diaz P, Harris J, Rosario F, Powell T, Jansson T . Increased placental fatty acid transporter 6 and binding protein 3 expression and fetal liver lipid accumulation in a mouse model of obesity in pregnancy. Am J Physiol Regul Integr Comp Physiol. 2015; 309(12):R1569-77. PMC: 4698418. DOI: 10.1152/ajpregu.00385.2015. View

4.
Li S, Shang T, Li S, Li Q . [Effects of peroxisome proliferator-activated receptor gamma and its ligands on cytotrophoblast invasion in first trimester of pregnancy and mechanism thereof]. Zhonghua Yi Xue Za Zhi. 2007; 87(3):174-8. View

5.
McCarthy F, Drewlo S, Kingdom J, Johns E, Walsh S, Kenny L . Peroxisome proliferator-activated receptor-γ as a potential therapeutic target in the treatment of preeclampsia. Hypertension. 2011; 58(2):280-6. DOI: 10.1161/HYPERTENSIONAHA.111.172627. View